China / Hong Chow Leaves Roche for Big New Role at Merck
In a big career move on a personal level and a sign of China’s continuing significance to global pharma, Hong…
Hutchison Medi Pharma
Last updated: 13.02.2014
Address: Building 4, 720 Cai Lun Road, Z.J. Hi-Tech Park,,China
Tel: (86）21 5079 0088
Web: http://www.hmplglobal.com/en/index.asp
Company description
Hutchison Medi Pharma is an entrepreneurial, China-based, global quality drug development company with a rich pipeline, first class R&D leadership and a proven track record.
Products and services
autoimmune diseases, oncology
Related
China / Sinopharm Tops Brand Value Rankings; Simcere Splashes $565M on Alzheimer’s Drug; Innovent-Ascentage Tie-Up A Sign of Biotech Deals to Come?
The latest news from the Chinese pharmaceutical industry, including recent deals between domestic pharma giant…
China / Fosun-Kite Yescarta Approval Signals Beginning of CAR-T Era
A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further…
China / First CAR-T Approval; AZ & Bayer Take VBP Hit; Lonza Boosts Manufacturing Capacity
The latest news from Chinese pharma, including a historic first approval for Fosun Kite’s CAR-T therapy Yescarta;…
China / New Country President for MSD Amid Changes at HQ & Access Challenges
MSD, which has had a presence in China since 1990, recently appointed Belgian national Anna van Acker to lead its…
China / A New Era of Reform Transforming Regulatory Professionals
Writing in the June edition of DIA’s Global Forum magazine, Harbour BioMed’s Fang Zhou, in conversation…
Hong Kong / HKEX’s Aim to Become World’s #1 Biotech Listing Hub & Challenges for New CEO
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs…
Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches…
China / Roche Hoping to Spearhead ‘Created in China’ Push with New Innovation Accelerator
In May 2021 Swiss giant Roche launched the ‘Roche Accelerator’ in Shanghai, a USD 31.1 million investment…
China / BioNTech-Fosun JV; Patent Law Revamp; Hong Kong as a Biotech Listing Hub
The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up…
China / EpimAb Looks to 2022 IPO & Global Leadership in Bispecific Antibodies
Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking…
Sizhen Wang – CEO & Co-Founder, Genetron Health
Genetron Health is a publicly-traded China-based precision oncology company, covering the “full-cycle” of…
